- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
vTv Therapeutics Stock (NASDAQ:VTVT), Quotes and News Summary
vTv Therapeutics Stock (NASDAQ: VTVT)
| Day Range0.88 - 0.92 | 52 Wk Range0.38 - 1.4 | Open / Close0.9 / 0.9 | Float / Outstanding44.9M / 81.5M |
| Vol / Avg.71.7K / 246.8K | Mkt Cap73.3M | P/E- | 50d Avg. Price1.05 |
| Div / Yield- | Payout Ratio- | Total Float44.9M | EPS-0.04 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-08 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | -0.040 | 0.0500 | ||||
| REV | 9.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
vTv Therapeutics Questions & Answers
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Other companies in vTv Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Connect Biopharma Hldgs (NASDAQ:CNTB), Lumos Pharma (NASDAQ:LUMO), Apexigen (NASDAQ:APGN) and TCR2 Therapeutics (NASDAQ:TCRR).
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by Northland Capital Markets on Wednesday, August 17, 2022. The analyst firm set a price target for 2.00 expecting VTVT to rise to within 12 months (a possible 122.22% upside). 2 analyst firms have reported ratings in the last year.
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $0.9 last updated September 27, 2022, 8:00 PM UTC.
There are no upcoming dividends for vTv Therapeutics.
vTv Therapeutics’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for vTv Therapeutics.
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.